Medtronic MDT Income Statement (2014-2026)

NYSE MDT
$92.34 -0.05 (-0.05%)
As of: Sep 9, 2026 · 12:42 PM EDT
Reported Financials

Medtronic Quarterly Income Statement

Periods 50 quarters
Latest Jul 2026

Medtronic reported revenue of $9.76B and net income of $1.48B for the quarter ended Jul 2026, up 13.7% year over year. This income statement covers 50 quarters of results from Apr 2014 through Jul 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Apr2014 Jul2014 Oct2014 Jan2015 Apr2015 Jul2015 Oct2015 Jan2016 Apr2016 Jul2016 Oct2016 Jan2017 Apr2017 Jul2017 Oct2017 Jan2018 Apr2018 Jul2018 Oct2018 Jan2019 Apr2019 Jul2019 Oct2019 Jan2020 Apr2020 Jul2020 Oct2020 Jan2021 Apr2021 Jul2021 Oct2021 Jan2022 Apr2022 Jul2022 Oct2022 Jan2023 Apr2023 Jul2023 Oct2023 Jan2024 Apr2024 Jul2024 Oct2024 Jan2025 Apr2025 Jul2025 Oct2025 Jan2026 Apr2026 Jul2026
Revenue & cost
Revenue
7.85B7.76B8.09B7.37B7.58B7.73B8.54B7.70B7.98B8.09B8.59B7.92B8.40B8.29B8.93B8.58B8.96B9.02B9.81B9.76B
Cost of RevenueCost of Rev
2.50B2.46B2.59B2.52B2.54B2.69B2.98B2.63B2.76B2.78B3.04B2.76B2.95B2.78B3.15B3.00B3.06B3.26B3.40B3.42B
Gross Profit
5.35B5.30B5.50B4.86B5.05B5.04B5.57B5.07B5.22B5.31B5.54B5.15B5.46B5.51B5.78B5.58B5.90B5.76B6.41B6.34B
Operating items
Amortization - Intangibles
0.43B0.43B0.43B0.42B0.42B0.43B0.40B0.43B0.42B0.42B0.40B0.41B0.41B0.42B0.56B0.46B0.46B0.44B0.44B0.41B
Research & DevelopmentR&D
0.68B0.67B0.65B0.69B0.68B0.69B0.64B0.67B0.70B0.69B0.68B0.68B0.70B0.68B0.68B0.73B0.75B0.72B0.67B0.77B
Selling, General & AdministrativeSG&A
2.62B2.56B2.57B2.57B2.62B2.62B2.62B2.61B2.69B2.67B2.77B2.65B2.76B2.72B2.72B2.81B2.96B2.96B3.06B3.20B
Restructuring CostsRestructuring
0.08B0.08B0.15B0.08B0.10B0.10B0.30B0.09B0.09B0.06B0.30B0.06B0.05B0.05B0.16B0.03B0.01B0.17B-0.14B
Other Operating ExpensesOther Opex
-0.02B0.06B-0.14B-0.04B0.10B0.12B-0.06B-0.00B0.03B-0.02B-0.48B-0.00B0.03B0.01B-0.01B-0.07B-0.02B-0.04B-0.16B-0.12B
Operating ExpensesOpex
3.37B3.31B3.38B3.33B3.39B3.41B3.56B3.37B3.48B3.42B3.74B3.39B3.50B3.44B3.57B3.56B3.73B3.85B3.59B3.97B
Operating IncomeOp. Inc
1.56B1.66B1.67B1.12B1.40B1.39B1.56B1.27B1.34B1.48B1.05B1.28B1.59B1.65B1.44B1.45B1.69B1.46B1.87B1.76B
EBIT
1.56B1.66B1.67B1.12B1.40B1.39B1.56B1.27B1.34B1.48B1.05B1.28B1.59B1.65B1.44B1.45B1.69B1.46B1.87B1.76B
Non-operating items
Non Operating Interest Expenses
0.14B0.14B0.14B0.16B0.12B0.17B0.19B0.15B0.18B0.19B0.20B0.17B0.21B0.18B0.17B0.18B0.18B0.18B0.18B0.19B
Interest & Investment IncomeInt & Inv Inc
Other Non Operating IncomeOther Non Op Inc.
0.07B0.07B0.07B0.08B0.11B0.15B0.17B0.08B0.15B0.18B0.01B0.16B0.17B0.07B-0.00B0.03B0.09B0.12B0.14B0.19B
Non Operating IncomeNon Op. Inc.
Net income details
EBT
1.49B1.59B1.60B1.04B1.40B1.38B1.55B1.20B1.31B1.47B0.85B1.27B1.56B1.54B1.26B1.30B1.60B1.40B1.83B1.77B
Tax ProvisionsTaxes
0.18B0.11B0.11B0.11B0.96B0.15B0.36B0.40B0.40B0.14B0.20B0.22B0.28B0.24B0.20B0.26B0.21B0.25B0.57B0.29B
Profit After TaxPAT
1.32B1.48B1.49B0.93B0.43B1.23B1.19B0.80B0.91B1.34B0.66B1.05B1.28B1.30B1.06B1.05B1.38B1.15B1.26B1.48B
Income from Non-Controlling InterestsInc. Minority
0.01B0.00B0.01B0.00B0.01B0.01B0.01B0.01B0.00B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.02B0.01B
Income from Continuing OperationsIncome (Continuing)
1.32B1.48B1.49B0.93B0.44B1.23B1.19B0.80B0.91B1.34B0.66B1.05B1.28B1.30B1.06B1.05B1.38B1.15B1.26B1.48B
Consolidated Net IncomeConsol Net Inc.
1.32B1.48B1.49B0.93B0.44B1.23B1.19B0.80B0.91B1.34B0.66B1.05B1.28B1.30B1.06B1.05B1.38B1.15B1.26B1.48B
Income towards Parent CompanyParent Net Inc
1.32B1.48B1.49B0.93B0.44B1.23B1.19B0.80B0.91B1.34B0.66B1.05B1.28B1.30B1.06B1.05B1.38B1.15B1.26B1.48B
Net Income towards Common StockholdersNet Income
1.32B1.48B1.49B0.93B0.44B1.23B1.19B0.80B0.91B1.34B0.66B1.05B1.28B1.30B1.06B1.05B1.38B1.15B1.26B1.48B
Additional items
EPS (Basic)
0.981.101.110.700.330.920.890.600.681.010.500.811.001.020.830.821.080.900.981.16
EPS (Diluted)
0.971.101.100.700.330.920.890.600.681.000.490.810.991.010.820.811.070.890.981.15
Shares Outstanding
1.35B1.34B1.34B1.33B1.33B1.33B1.33B1.33B1.33B1.33B1.33B1.29B1.28B1.28B1.29B1.28B1.28B1.28B1.28B1.28B
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
1.36B1.35B1.35B1.33B1.33B1.33B1.33B1.33B1.33B1.33B1.33B1.30B1.29B1.29B1.29B1.29B1.29B1.29B1.29B1.29B
Shares Outstanding (Entity)Shares Outstanding (Entity.)
1.34B1.34B1.33B1.33B1.33B1.33B1.33B1.33B1.33B1.33B1.31B1.28B1.28B1.28B1.28B1.28B1.28B1.28B1.28B1.28B
EBITDA
1.56B1.66B1.67B1.12B1.40B1.39B1.56B1.27B1.34B1.48B1.05B1.28B1.59B1.65B1.44B1.45B1.69B1.46B1.87B1.76B
Interest ExpensesInt Expense
0.14B0.14B0.14B0.16B0.12B0.17B0.19B0.15B0.18B0.19B0.20B0.17B0.21B0.18B0.17B0.18B0.18B0.18B0.18B0.19B
Tax Rate
11.79%6.67%6.87%10.73%68.75%10.62%23.34%33.44%30.62%9.17%23.04%17.35%18.02%15.39%15.78%19.59%13.46%18.09%31.35%16.34%